HITS is a biotech startup aiming to develop meaningful digital solutions to accelerate the drug development process and introduce a new paradigm of drug discovery.
We use both physics-based computational methods and data-driven approaches including state-of-the-art AI techniques. These methods are integrated seamlessly into a fully automated platform on top of clouding computing systems, leading to a unique and yet powerful solution with high accuracy and blazing speed.
The performance of the HITS platform has been verified by multiple experiments through collaborations with major domestic drug discovery companies such as LG Chemistry, Ildong, HKinnoN, Chong Kun Dang, Boryung, and TheragenBio.
We transform the conventional pipeline structure into an innovative network structure.
Our ultimate goal is to establish a new drug development ecosystem where universities, research centers, SMEs, and conglomerates can freely share information and maximize their research output.
Company Details
- Employees
- 63
- Address
- 강남구 테헤란로4길 28 송민빌딩 8층, 서울특별시,06241,korea, Republic Of
- Industry
- It Services And It Consulting
- NAICS
-
Computer Systems Design and Related ServicesOther Computer Related Services
- Website
- https://hits.ai/
- Keywords
- Hit Discovery, Hit-to-Lead, Lead Optimization, Artificial Intelligence, Deep Learning, Virtual Screening.
- HQ
- 서울특별시
Hits Questions
Hits's website is https://hits.ai/
Hits's LinkedIn profile is https://kr.linkedin.com/company/hits-ai
Hits has
63 employees.
View email and phone details for 63
employees at Hits.
Hits's industry is
IT Services and IT Consulting
Hits's top competitors are
Hits Corporation,
Hits Solutions,
Hits Careers,
Kije's Lab,
Publy,
Hits Consulting,
42dot,
Hitss Brasil,
Letsur,
Meissa Group.
Hits's categories are IT Services and IT Consulting
